Ennov

Executive Summary

Ennov is a French digital health company that provides a unified, AI-powered content and information management platform specifically designed for the life sciences industry. Founded in 2002 and headquartered in Paris, Ennov serves over 450 life sciences companies globally, supporting regulated processes across the entire product lifecycle including Regulatory, Quality, Clinical, Pharmacovigilance, and Commercial operations. By eliminating data silos and ensuring compliance with stringent industry regulations, Ennov's platform helps pharmaceutical, biotech, and medical device companies improve efficiency and accelerate time-to-market. The company's long-standing presence and broad customer base underscore its reliability and deep domain expertise in managing complex, mission-critical content and workflows for regulated environments.

Upcoming Catalysts (preview)

• Q3 2026Launch of enhanced AI/ML module for automated regulatory submission80% success
• Q3 2026Strategic partnership with a top-20 pharmaceutical company for enterprise-wide deployment60% success
• Q3 2026Expansion of pharmacovigilance compliance features to address new EU regulatory requirements90% success